Arterial Tissue Regeneration for Pediatric Applications: Inspiration From Up-to-Date Tissue-Engineered Vascular Bypass Grafts

Artificial Organs

Volumn 37, Issue 5, 2013, Pages 423-434

  Cittadella, Giorgio ^a   de Mel, Achala ^a   Dee, Ryan ^a   De Coppi, Paolo ^b   Seifalian, Alexander M ^a,c  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

Autologous cells; Regenerative; Small diameter grafts; Tissue engineering

Indexed keywords

CELL ENGINEERING; HISTOLOGY; PHYSIOLOGY; SCAFFOLDS (BIOLOGY); TISSUE; TISSUE REGENERATION;

ARTERIAL TISSUE; AUTOLOGOUS CELL; AUTOLOGOUS TISSUE; BYPASS GRAFT; CLINICAL TRIAL; REGENERATIVE; SMALL DIAMETER GRAFT; TISSUE ENGINEERED VASCULAR GRAFTS; TISSUES ENGINEERINGS; VASCULAR SURGERY;

PEDIATRICS;

POLYGLYCOLIC ACID; POLYLACTIC ACID; TISSUE SCAFFOLD;

ARTERY PROSTHESIS; BLOOD VESSEL GRAFT; BLOOD VESSEL SHUNT; CHILD HEALTH CARE; CLINICAL PRACTICE; EXTRACELLULAR MATRIX; HOMEOSTASIS; HUMAN; IMPLANT; NONHUMAN; PRIORITY JOURNAL; REVIEW; TISSUE ENGINEERED VASCULAR GRAFT; TISSUE ENGINEERING; TISSUE REGENERATION;

EID: 84876797624     PISSN: 0160564X     EISSN: 15251594     Source Type: Journal    
DOI: 10.1111/aor.12022     Document Type: Review

References (83)

1. Hirsch AT, Allison MA, Gomes AS, etal. A call to action: women and peripheral artery disease: a scientific statement from the American Heart Association. Circulation 2012;125:1449-1472.
2. Saha SP, Whayne TF Jr, Mukherjee D. Current evidence for antithrombotic therapy after peripheral vascular interventions. Curr Vasc Pharmacol 2012 Jan 20. [Epub ahead of print].
3. Lau KK, Jones DP, Gaber O, Nezakatgoo N. Use of a "composite" vascular access graft in a young child on hemodialysis. Hemodial Int 2007;11:190-192.
4. Chamiot-Clerc P, Copie X, Renaud JF, Safar M, Girerd X. Comparative reactivity and mechanical properties of human isolated internal mammary and radial arteries. Cardiovasc Res 1998;37:811-819.
5. Twine CP, McLain AD. Graft type for femoro-popliteal bypass surgery. Cochrane Database Syst Rev 2010;(5):CD001487.
6. Desai M, Seifalian AM, Hamilton G. Role of prosthetic conduits in coronary artery bypass grafting. Eur J Cardiothorac Surg 2011;40:394-398.
7. Sarkar S, Sales KM, Hamilton G, Seifalian AM. Addressing thrombogenicity in vascular graft construction. J Biomed Mater Res B Appl Biomater 2007;82:100-108.
8. Chiesa R, Astore D, Frigerio S, etal. Vascular prosthetic graft infection: epidemiology, bacteriology, pathogenesis and treatment. Acta Chir Belg 2002;102:238-247.
9. Harish A, Allon M. Arteriovenous graft infection: a comparison of thigh and upper extremity grafts. Clin J Am Soc Nephrol 2011;6:1739-1743.
10. Samanek M. Children with congenital heart disease: probability of natural survival. Pediatr Cardiol 1992;13:152-158.
11. Starr JP. Tetralogy of Fallot: yesterday and today. World J Surg 2010;34:658-668.
12. Kim SJ, Kim WH, Lim HG, Lee JY. Outcome of 200 patients after an extracardiac Fontan procedure. J Thorac Cardiovasc Surg 2008;136:108-116.
13. Kitamura S, Tsuda E, Kobayashi J, etal. Twenty-five-year outcome of pediatric coronary artery bypass surgery for Kawasaki disease. Circulation 2009;120:60-68.
14. Legendre A, Chantepie A, Belli E, etal. Outcome of coronary artery bypass grafting performed in young children. J Thorac Cardiovasc Surg 2010;139:349-353.
15. Meyers RL, Lowichik A, Kraiss LW, Hawkins JA. Aortoiliac reconstruction in infants and toddlers: replacement with decellularized branched pulmonary artery allograft. J Pediatr Surg 2006;41:226-229.
16. Mayer JE Jr, Shin'oka T, Shum-Tim D. Tissue engineering of cardiovascular structures. Curr Opin Cardiol 1997;12:528-532.
17. Shin'oka T, Imai Y, Ikada Y. Transplantation of a tissue-engineered pulmonary artery. N Engl J Med 2001;344:532-533.
18. Matsumura G, Hibino N, Ikada Y, Kurosawa H, Shin'oka T. Successful application of tissue engineered vascular autografts: clinical experience. Biomaterials 2003;24:2303-2311.
19. Peck M, Gebhart D, Dusserre N, McAllister TN, L'Heureux N. The evolution of vascular tissue engineering and current state of the art. Cells Tissues Organs 2012;195:144-158.
20. Shinoka T, Shum-Tim D, Ma PX, etal. Creation of viable pulmonary artery autografts through tissue engineering. J Thorac Cardiovasc Surg 1998;115:536-545.
21. Dahl SL, Koh J, Prabhakar V, Niklason LE. Decellularized native and engineered arterial scaffolds for transplantation. Cell Transplant 2003;12:659-666.
22. Baguneid M, de Mel A, Yildirimer L, Fuller BJ, Hamilton G, Seifalian AM. In vivo study of a model tissue-engineered small-diameter vascular bypass graft. Biotechnol Appl Biochem 2011;58:14-24.
23. Dahl SL, Kypson AP, Lawson JH, etal. Readily available tissue-engineered vascular grafts. Sci Transl Med 2011;3:68ra9.
24. Neff LP, Tillman BW, Yazdani SK, etal. Vascular smooth muscle enhances functionality of tissue-engineered blood vessels in vivo. J Vasc Surg 2011;53:426-434.
25. Sundaram S, Niklason LE. Smooth muscle and other cell sources for human blood vessel engineering. Cells Tissues Organs 2012;195:15-25.
26. Mooney JE, Rolfe BE, Osborne GW, etal. Cellular plasticity of inflammatory myeloid cells in the peritoneal foreign body response. Am J Pathol 2010;176:369-380.
27. Sparks CH. Autogenous grafts made to order. Ann Thorac Surg 1969;8:104-113.
28. Hibino N, Shin'oka T, Matsumura G, Ikada Y, Kurosawa H. The tissue-engineered vascular graft using bone marrow without culture. J Thorac Cardiovasc Surg 2005;129:1064-1070.
29. Matsumura G, Miyagawa-Tomita S, Shin'oka T, Ikada Y, Kurosawa H. First evidence that bone marrow cells contribute to the construction of tissue-engineered vascular autografts in vivo. Circulation 2003;108:1729-1734.
30. Hibino N, McGillicuddy E, Matsumura G, etal. Late-term results of tissue-engineered vascular grafts in humans. J Thorac Cardiovasc Surg 2010;139:431-436, 436.e1-2.
31. Shin'oka T, Matsumura G, Hibino N, etal. Midterm clinical result of tissue-engineered vascular autografts seeded with autologous bone marrow cells. J Thorac Cardiovasc Surg 2005;129:1330-1338.
32. Udelsman B, Hibino N, Villalona GA, etal. Development of an operator-independent method for seeding tissue-engineered vascular grafts. Tissue Eng Part C Methods 2011;17:731-736.
33. Liu JY, Swartz DD, Peng HF, Gugino SF, Russell JA, Andreadis ST. Functional tissue-engineered blood vessels from bone marrow progenitor cells. Cardiovasc Res 2007;75:618-628.
34. Roh JD, Nelson GN, Brennan MP, etal. Small-diameter biodegradable scaffolds for functional vascular tissue engineering in the mouse model. Biomaterials 2008;29:1454-1463.
35. Roh JD, Sawh-Martinez R, Brennan MP, etal. Tissue-engineered vascular grafts transform into mature blood vessels via an inflammation-mediated process of vascular remodeling. Proc Natl Acad Sci U S A 2010;107:4669-4674.
36. Hibino N, Villalona G, Pietris N, etal. Tissue-engineered vascular grafts form neovessels that arise from regeneration of the adjacent blood vessel. FASEB J 2011;25:2731-2739.
37. Klein D, Weisshardt P, Kleff V, Jastrow H, Jakob HG, Ergun S. Vascular wall-resident CD44+ multipotent stem cells give rise to pericytes and smooth muscle cells and contribute to new vessel maturation. PLoS ONE 2011;6:e20540.
38. Harrington JK, Chahboune H, Criscione JM, etal. Determining the fate of seeded cells in venous tissue-engineered vascular grafts using serial MRI. FASEB J 2011;25:4150-4161.
39. Hibino N, Yi T, Duncan DR, etal. A critical role for macrophages in neovessel formation and the development of stenosis in tissue-engineered vascular grafts. FASEB J 2011;25:4253-4263.
40. Ahmed M, Ghanbari H, Cousins BG, Hamilton G, Seifalian AM. Small calibre polyhedral oligomeric silsesquioxane nanocomposite cardiovascular grafts: influence of porosity on the structure, haemocompatibility and mechanical properties. Acta Biomater 2011;7:3857-3867.
41. Ghanbari H, de Mel A, Seifalian AM. Cardiovascular application of polyhedral oligomeric silsesquioxane nanomaterials: a glimpse into prospective horizons. Int J Nanomedicine 2011;6:775-786.
42. Rahmani B, Tzamtzis S, Ghanbari H, Burriesci G, Seifalian AM. Manufacturing and hydrodynamic assessment of a novel aortic valve made of a new nanocomposite polymer. J Biomech 2012;45:1205-1211.
43. Chaloupka K, Motwani M, Seifalian AM. Development of a new lacrimal drainage conduit using POSS nanocomposite. Biotechnol Appl Biochem 2011;58:363-370.
44. Jungebluth P, Alici E, Baiguera S, etal. Tracheobronchial transplantation with a stem-cell-seeded bioartificial nanocomposite: a proof-of-concept study. Lancet 2011;378:1997-2004.
45. Marelli B, Alessandrino A, Fare S, Freddi G, Mantovani D, Tanzi MC. Compliant electrospun silk fibroin tubes for small vessel bypass grafting. Acta Biomater 2010;6:4019-4026.
46. Enomoto S, Sumi M, Kajimoto K, etal. Long-term patency of small-diameter vascular graft made from fibroin, a silk-based biodegradable material. J Vasc Surg 2010;51:155-164.
47. McClure MJ, Sell SA, Ayres CE, Simpson DG, Bowlin GL. Electrospinning-aligned and random polydioxanone-polycaprolactone-silk fibroin-blended scaffolds: geometry for a vascular matrix. Biomed Mater 2009;4:055010.
48. de Mel A, Jell G, Stevens MM, Seifalian AM. Biofunctionalization of biomaterials for accelerated in situ endothelialization: a review. Biomacromolecules 2008;9:2969-2979.
49. de Mel A, Punshon G, Ramesh B, etal. In situ endothelialization potential of a biofunctionalised nanocomposite biomaterial-based small diameter bypass graft. Biomed Mater Eng 2009;19:317-331.
50. Herring M, Gardner A, Glover J. A single-staged technique for seeding vascular grafts with autogenous endothelium. Surgery 1978;84:498-504.
51. Meinhart JG, Deutsch M, Fischlein T, Howanietz N, Froschl A, Zilla P. Clinical autologous in vitro endothelialization of 153 infrainguinal ePTFE grafts. Ann Thorac Surg 2001;71:S327-S331.
52. Baguneid MS, Seifalian AM, Salacinski HJ, Murray D, Hamilton G, Walker MG. Tissue engineering of blood vessels. Br J Surg 2006;93:282-290.
53. de Mel A, Murad F, Seifalian AM. Nitric oxide: a guardian for vascular grafts? Chem Rev 2011;111:5742-5767.
54. Kidane AG, Salacinski H, Tiwari A, Bruckdorfer KR, Seifalian AM. Anticoagulant and antiplatelet agents: their clinical and device application(s) together with usages to engineer surfaces. Biomacromolecules 2004;5:798-813.
55. Hagensen MK, Raarup MK, Mortensen MB, etal. Circulating endothelial progenitor cells do not contribute to regeneration of endothelium after murine arterial injury. Cardiovasc Res 2012;93:223-231.
56. L'Heureux N, Germain L, Labbe R, Auger FA. In vitro construction of a human blood vessel from cultured vascular cells: a morphologic study. J Vasc Surg 1993;17:499-509.
57. Weinberg CB, Bell E. A blood vessel model constructed from collagen and cultured vascular cells. Science 1986;231:397-400.
58. L'Heureux N, Paquet S, Labbe R, Germain L, Auger FA. A completely biological tissue-engineered human blood vessel. FASEB J 1998;12:47-56.
59. L'Heureux N, Dusserre N, Konig G, etal. Human tissue-engineered blood vessels for adult arterial revascularization. Nat Med 2006;12:361-365.
60. McKee JA, Banik SS, Boyer MJ, etal. Human arteries engineered in vitro. EMBO Rep 2003;4:633-638.
61. L'Heureux N, McAllister TN, de la Fuente LM. Tissue-engineered blood vessel for adult arterial revascularization. N Engl J Med 2007;357:1451-1453.
62. McAllister TN, Maruszewski M, Garrido SA, etal. Effectiveness of haemodialysis access with an autologous tissue-engineered vascular graft: a multicentre cohort study. Lancet 2009;373:1440-1446.
63. Wystrychowski W, Cierpka L, Zagalski K, etal. Case study: first implantation of a frozen, devitalized tissue-engineered vascular graft for urgent hemodialysis access. J Vasc Access 2011;12:67-70.
64. Weber B, Emmert MY, Schoenauer R, Brokopp C, Baumgartner L, Hoerstrup SP. Tissue engineering on matrix: future of autologous tissue replacement. Semin Immunopathol 2011;33:307-315.
65. Liberski AR, Delaney JT Jr, Schafer H, Perelaer J, Schubert US. Organ weaving: woven threads and sheets as a step towards a new strategy for artificial organ development. Macromol Biosci 2011;11:1491-1498.
66. Matsumoto T, Holmes RH, Burdick CO, Heisterkamp CA III, O'Connell TJ Jr. The fate of the inverted segment of small bowel used for the replacement of major veins. Surgery 1966;60:739-743.
67. Huynh T, Abraham G, Murray J, Brockbank K, Hagen PO, Sullivan S. Remodeling of an acellular collagen graft into a physiologically responsive neovessel. Nat Biotechnol 1999;17:1083-1086.
68. Fiore AC, Brown JW, Turrentine MW, etal. A bovine jugular vein conduit: a ten-year bi-institutional experience. Ann Thorac Surg 2011;92:183-190.
69. Darby CR, Roy D, Deardon D, Cornall A. Depopulated bovine ureteric xenograft for complex haemodialysis vascular access. Eur J Vasc Endovasc Surg 2006;31:181-186.
70. Chemla ES, Morsy M. Randomized clinical trial comparing decellularized bovine ureter with expanded polytetrafluoroethylene for vascular access. Br J Surg 2009;96:34-39.
71. Spark JI, Yeluri S, Derham C, Wong YT, Leitch D. Incomplete cellular depopulation may explain the high failure rate of bovine ureteric grafts. Br J Surg 2008;95:582-585.
72. Mathapati S, Verma RS, Cherian KM, Guhathakurta S. Inflammatory responses of tissue-engineered xenografts in a clinical scenario. Interact Cardiovasc Thorac Surg 2011;12:360-365.
73. Keane TJ, Londono R, Turner NJ, Badylak SF. Consequences of ineffective decellularization of biologic scaffolds on the host response. Biomaterials 2012;33:1771-1781.
74. Brown BN, Londono R, Tottey S, etal. Macrophage phenotype as a predictor of constructive remodeling following the implantation of biologically derived surgical mesh materials. Acta Biomater 2012;8:978-987.
75. Teebken OE, Puschmann C, Rohde B, etal. Human iliac vein replacement with a tissue-engineered graft. Vasa 2009;38:60-65.
76. Weber B, Zeisberger SM, Hoerstrup SP. Prenatally harvested cells for cardiovascular tissue engineering: fabrication of autologous implants prior to birth. Placenta 2011;32(Suppl. 4):S316-S319.
77. Hibino N, Duncan DR, Nalbandian A, etal. Evaluation of the use of an induced puripotent stem cell sheet for the construction of tissue-engineered vascular grafts. J Thorac Cardiovasc Surg 2012;143:696-703.
78. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006;126:663-676.
79. Kim K, Zhao R, Doi A, etal. Donor cell type can influence the epigenome and differentiation potential of human induced pluripotent stem cells. Nat Biotechnol 2011;29:1117-1119.
80. Ratajczak MZ, Kucia M, Jadczyk T, etal. Pivotal role of paracrine effects in stem cell therapies in regenerative medicine: can we translate stem cell-secreted paracrine factors and microvesicles into better therapeutic strategies? Leukemia 2012;26:1166-1173.
81. de Mel A, Chaloupka K, Malam Y, Darbyshire A, Cousins B, Seifalian AM. A silver nanocomposite biomaterial for blood-contacting implants. J Biomed Mater Res A 2012;100:2348-2357.
82. Loizidou M, Seifalian AM. Nanotechnology and its applications in surgery. Br J Surg 2010;97:463-465.
83. Riley PR, Smart N. Vascularizing the heart. Cardiovasc Res 2011;91:260-268.